Independent nurse prescriber Anna Baker was invited to speak at Cosmedicon 2023 in Australia in March on behalf of IBSA Derma.
Medical aesthetic company Evolus has announced that its neurotoxin Nuceiva has received approval for sale in Australia.
Pharmaceutical company IBSA Derma has launched its Profhilo line in Australia and New Zealand.
The Australian government’s Therapeutic Goods Administration (TGA) has introduced new regulations preventing social media influencers being paid to endorse health, cosmetic and skincare goods (therapeutic goods).
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979
